Apellis Pharmaceuticals Inc. (APLS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Apellis Pharmaceuticals I...

NASDAQ: APLS · Real-Time Price · USD
22.37
0.15 (0.68%)
At close: Sep 26, 2025, 3:59 PM
22.30
-0.31%
After-hours: Sep 26, 2025, 04:43 PM EDT

Apellis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
411.29M 351.19M 551.8M 640.19M
Short-Term Investments
n/a 1.11M 6.5M 60.36M
Long-Term Investments
n/a 3.24M n/a n/a
Other Long-Term Assets
77.06M -1.93M 15.8M 31.64M
Receivables
271.72M 206.44M 7.73M 10.1M
Inventory
81.4M 146.36M 85.71M 16.29M
Other Current Assets
6.17M 22.41M 36.66M 72.24M
Total Current Assets
788.95M 766.33M 719.52M 824.05M
Property-Plant & Equipment
19.04M 21.09M 24.89M 26.08M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
96.1M 22.4M 40.69M 57.72M
Total Assets
885.05M 788.73M 760.22M 881.76M
Account Payables
38.57M 37.52M 37.34M 16.91M
Deferred Revenue
n/a n/a n/a 103.24M
Short-Term Debt
6.75M n/a n/a n/a
Other Current Liabilities
140.18M 75.83M 81.43M 7.58M
Total Current Liabilities
185.51M 247.59M 167.61M 131.85M
Long-Term Debt
452.83M 93.03M 92.74M 189.02M
Other Long-Term Liabilities
7.97M 242.13M 315.65M 345.15M
Total Long-Term Liabilities
471M 346.62M 422.74M 551.26M
Total Liabilities
656.51M 594.21M 590.35M 683.1M
Total Debt
469.78M 110.93M 112.71M 210.22M
Book Value
228.54M 194.52M 169.87M 198.66M
Book Value Per Share
1.84 1.64 1.60 2.35
Common Stock
12K 12K 11K 10K
Retained Earnings
-3.04B -2.84B -2.31B -1.66B
Comprehensive Income
-3.31M -3.54M -875K -2.09M
Shareholders Equity
228.54M 194.52M 169.87M 198.66M
Total Investments
n/a 4.35M 6.5M 60.36M